European Leukemia Trial Registry
Trial: ALL Forodesin in B-Precursor ALL

More Details
Title Forodesine Hydrochloride Infusion in Patients with B-cell Acute Lymphoblastic Leukemia
Scientific Title A Phase I/II, Multi-Center, Open-Label, Repeat-Dose Study of Forodesine Hydrochloride Infusion in Patients with B-Cell Acute Lymphoblastic Leukemia with an Option of Extended Use of Forodesine Hydrochloride
Short Title ALL Forodesin in B-Precursor ALL
Trialgroup GMALL
Type of Trial multicentric, open-label
Disease Acute lymphoblastic leukemia(ALL) B-Precursor ALL
Age All ages
Status Closed
Start of Recruitment 01.01.2006
Leader Hoelzer, Prof. Dr. med., Dieter
Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 19.09.2006 Anja Hellenbrecht
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org